ConductScience.org, home

Paper3933532

The effects of cyclosporin A on the immune system.

Shevach EM. Annu Rev Immunol, 1985. Cited by 621 papers, by iCite.

Cite this record

ConductScience Library. The effects of cyclosporin A on the immune system. Papers, record 3933532. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3933532

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effects of cyclosporin A on the immune system.
PubMed
Journal
Annu Rev Immunol
PubMed
Year
1985
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
621
iCite
Relative citation ratio, by iCite
17.8
iCite
Revised in PubMed
2022-03-17
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shevach EME M

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CyclosporinsMajor topic
Immune SystemMajor topic
Animals
Autoimmune Diseases
B-Lymphocytes
Clone Cells
Graft Rejection
Humans
Hybridomas
In Vitro Techniques
Interleukin-2
Lymphocyte Activation
Lymphokines
Mice
Receptors, Immunologic
Receptors, Interleukin-2
T-Lymphocytes
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by115

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 621 citations.

PMIDTitleJournalYearIn PapersSource
35739412Mitochondrial Permeability Transition in Stem Cells, Development, and Disease.Adv Exp Med Biol2023https://conductscience.org/library/papers/35739412PubMed
35224236Protein-protein interface analysis of the non-ribosomal peptide synthetase peptidyl carrier protein and enzymatic domains.Synth Syst Biotechnol2022https://conductscience.org/library/papers/35224236PubMed
34552938Cyclosporin A: A Repurposable Drug in the Treatment of COVID-19?Front Med (Lausanne)2021https://conductscience.org/library/papers/34552938PubMed
33337128l-Threonine Transaldolase Activity Is Enabled by a Persistent Catalytic Intermediate.ACS Chem Biol2021https://conductscience.org/library/papers/33337128PubMed
30984176Lessons to Learn From Low-Dose Cyclosporin-A: A New Approach for Unexpected Clinical Applications.Front Immunol2019https://conductscience.org/library/papers/30984176PubMed
29892147In Vivo Comparative Evaluation of the Pomegranate (Punica granatum) Peel Extract as an Alternative Agent to Nystatin against Oral Candidiasis.Iran J Med Sci2018https://conductscience.org/library/papers/29892147PubMed
27358055The epoxyeicosatrienoic acid analog PVPA ameliorates cyclosporine-induced hypertension and renal injury in rats.Am J Physiol Renal Physiol2016https://conductscience.org/library/papers/27358055PubMed
25902927Impact of irradiation and immunosuppressive agents on immune system homeostasis in rhesus macaques.Clin Exp Immunol2015https://conductscience.org/library/papers/25902927PubMed
24216163Immunosuppressive activity of an aqueous Viola tricolor herbal extract.J Ethnopharmacol2014https://conductscience.org/library/papers/24216163PubMed
23840803Cyclotides Suppress Human T-Lymphocyte Proliferation by an Interleukin 2-Dependent Mechanism.PLoS One2013https://conductscience.org/library/papers/23840803PubMed
23406403Heteropterys tomentosa (A. Juss.) infusion counteracts Cyclosporin a side effects on the ventral prostate.BMC Complement Altern Med2013https://conductscience.org/library/papers/23406403PubMed
21562466Consecutive low doses of cyclosporine A induce pro-inflammatory cytokines and accelerate allograft skin rejection.Molecules2011https://conductscience.org/library/papers/21562466PubMed
21035406CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.Cancer Cell2010https://conductscience.org/library/papers/21035406PubMed
20300548The dual role of calcium as messenger and stressor in cell damage, death, and survival.Int J Cell Biol2010https://conductscience.org/library/papers/20300548PubMed
16622732High-turnover osteoporosis is induced by cyclosporin A in rats.J Bone Miner Metab2006https://conductscience.org/library/papers/16622732PubMed
15493267The phenotypic and molecular characterization of Nb2 lymphoma cells activated with IL-2 and human growth hormone.Immunology1989https://conductscience.org/library/papers/15493267PubMed
14592756Vacuolating encephalitis in mice infected by human coronavirus OC43.Virology2003https://conductscience.org/library/papers/14592756PubMed
12827216Effects of immunomodulators on airways hyperresponsiveness to adenosine induced in actively sensitised Brown Norway rats by exposure to allergen.Naunyn Schmiedebergs Arch Pharmacol2003https://conductscience.org/library/papers/12827216PubMed
12412760Immunosuppression with cyclosporin A alters the thymic microenvironment.Clin Exp Immunol1989https://conductscience.org/library/papers/12412760PubMed
11683964Topical tacrolimus and cyclosporin A differentially inhibit early and late effector phases of cutaneous delayed-type and immunoglobulin E hypersensitivity.Immunology2001https://conductscience.org/library/papers/11683964PubMed

See all 115 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3933532

GET https://conductscience.org/api/papers/v1/3933532/cited_by?page=2